newsPharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, September 20217 September 2021 | By Anna Begley (European Pharmaceutical Review)The EMA’s drug safety committee (PRAC) reviewed COVID-19 vaccine risks and issued a new safety signal for Imbruvica with rituximab.
newsBeta-blocker therapy after heart attack questioned19 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Researchers have found that beta blockers are not needed after a heart attack if survivors are taking ACE inhibitors and statins...